Literature DB >> 26921024

Falling demand for mefloquine threatens future of this important antimalarial, experts warn.

Nigel Hawkes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26921024     DOI： 10.1136/bmj.i1190

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada.

Authors:  Remington L Nevin; Aricia M Byrd
Journal:  Neurol Ther       Date:  2016-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.